This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Leo-Pharma A/s. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Christoph Erkel: Innovator in Antibody Development
Introduction
Christoph Erkel is a notable inventor based in Planegg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting specific proteins. His work has implications for therapeutic applications, especially in the context of inflammatory diseases.
Latest Patents
Christoph Erkel holds a patent for "IL-1 receptor accessory protein-inhibiting antibodies and antigen-binding fragments thereof." This patent provides novel antibodies and fragments that specifically target IL-1RAcP (Interleukin-1 receptor accessory protein). The use of IL-1RAcP inhibitors is also detailed in this disclosure, showcasing the potential for new therapeutic strategies.
Career Highlights
Erkel is currently associated with Leo Pharma A/S, a company known for its focus on dermatology and other therapeutic areas. His role at Leo Pharma A/S allows him to leverage his expertise in antibody development to advance innovative treatments.
Collaborations
Some of Christoph Erkel's notable coworkers include Birgitte Ursø and Waseem Sajid. Their collaborative efforts contribute to the ongoing research and development initiatives within their organization.
Conclusion
Christoph Erkel's work in developing IL-1RAcP inhibitors represents a significant advancement in therapeutic antibody research. His contributions continue to influence the field and hold promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile